Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

DCAF7 anticorps (N-Term)

DCAF7 Reactivité: Humain, Souris WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN928603
  • Antigène Voir toutes DCAF7 Anticorps
    DCAF7 (DDB1 and CUL4 Associated Factor 7 (DCAF7))
    Épitope
    • 15
    • 14
    • 7
    • 4
    • 2
    N-Term
    Reactivité
    • 32
    • 29
    • 12
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain, Souris
    Hôte
    • 45
    • 2
    Lapin
    Clonalité
    • 47
    Polyclonal
    Conjugué
    • 16
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp DCAF7 est non-conjugé
    Application
    • 37
    • 18
    • 13
    • 13
    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    Western Blotting (WB)
     Réactivité croisée
    Souris
    Purification
    Purified
    Immunogène
    Dcaf7 antibody was raised in rabbit using the N terminal of Dcaf7 as the immunogen
    Top Product
    Discover our top product DCAF7 Anticorps primaire
  • Indications d'application
    Optimal conditions should be determined by the investigator.
    Commentaires

    Dcaf7 Blocking Peptide, catalog no. 33R-8588, is also available for use as a blocking control in assays to test for specificity of this Dcaf7 antibody

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    Lot specific
    Buffer
    Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
  • Antigène
    DCAF7 (DDB1 and CUL4 Associated Factor 7 (DCAF7))
    Autre désignation
    Dcaf7 (DCAF7 Produits)
    Synonymes
    anticorps wdr68, anticorps han11l, anticorps fj83g06, anticorps zgc:63940, anticorps wu:fj83g06, anticorps cg14614, anticorps MGC53476, anticorps MGC80168, anticorps MGC75622, anticorps WDR68, anticorps AN11, anticorps HAN11, anticorps SWAN-1, anticorps 1700012F10Rik, anticorps 2610037L01Rik, anticorps C86529, anticorps Wdr68, anticorps RGD1305140, anticorps ddb1 and cul4 associated factor 7, anticorps DDB1 and CUL4 associated factor 7 S homeolog, anticorps DDB1 and CUL4 associated factor 7, anticorps dcaf7, anticorps dcaf7.S, anticorps DCAF7, anticorps Dcaf7
    Sujet
    Dcaf7 is involved in craniofacial development. It acts upstream of the EDN1 pathway and is required for formation of the upper jaw equivalent, the palatoquadrate. The activity required for EDN1 pathway function differs between the first and second arches. It associates with DIAPH1 and controls GLI1 transcriptional activity. It could be involved in skin development. It may function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex. Synonyms: Polyclonal Dcaf7 antibody, Anti-Dcaf7 antibody, DDB1 and CUL4 associated factor 7 antibody, 1700012F10Rik antibody, 2610037L01Rik antibody, C86529 antibody, HAN11 antibody, Wdr68 antibody.
    Pathways
    SARS-CoV-2 Protein Interactome
Vous êtes ici:
Support technique